Nuvalent (NUVL) Liabilities and Shareholders Equity (2020 - 2026)
Nuvalent (NUVL) posted Liabilities and Shareholders Equity of $1.33 billion for Q1 2026, up 20.4% from $1.11 billion a year earlier but down 5.8% from the prior quarter.
Powered by 
Analysis
Nuvalent (NUVL) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Nuvalent's Liabilities and Shareholders Equity came in at $1.41 billion, up 23.7% from FY2024.
- Annual Liabilities and Shareholders Equity has increased for four consecutive years, with a five-year compound annual growth rate of 165.8% (FY2020 to FY2025).
- In prior years, Nuvalent's Liabilities and Shareholders Equity was $1.14 billion in FY2024 (+55.9%), $732.38 million in FY2023 (+51.8%), $482.46 million in FY2022 (+64.2%) and $293.82 million in FY2021.
- Quarterly Liabilities and Shareholders Equity has run from a low of $143.5 million in Q2 2021 to a high of $1.41 billion in Q4 2025 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in seven of the last eight quarters, with growth averaging 53.1%.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2024, with growth of 179.7%; the weakest was Q3 2022, with a decline of 19.0%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $1.41 billion (Q4 2025), $979.91 million (Q3 2025) and $1.04 billion (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 1.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.33 Bn |
| Dec 31, 2025 | 1.41 Bn |
| Sep 30, 2025 | 979.91 Mn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.11 Bn |
| Dec 31, 2024 | 1.14 Bn |
| Sep 30, 2024 | 1.19 Bn |
| Jun 30, 2024 | 675.23 Mn |
| Mar 31, 2024 | 708.47 Mn |
| Dec 31, 2023 | 732.38 Mn |
| Sep 30, 2023 | 425.08 Mn |
| Jun 30, 2023 | 441.95 Mn |
| Mar 31, 2023 | 460.99 Mn |
| Dec 31, 2022 | 482.46 Mn |
| Sep 30, 2022 | 249.56 Mn |
| Jun 30, 2022 | 263.02 Mn |
| Mar 31, 2022 | 277.04 Mn |
| Dec 31, 2021 | 293.82 Mn |
| Sep 30, 2021 | 307.97 Mn |
| Jun 30, 2021 | 143.50 Mn |
API Access
Nuvalent Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NUVL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NUVL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NUVL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();